-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster III

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Hillard M Lazarus, MD1, Joseph P. McGuirk, DO2, Tsila Zuckerman, MD3,4, Leland Metheny, MD5, Luis Pineiro, MD6*, Mark R. Litzow, MD7, Scott D. Rowley, MD8, Batia Avni9*, Roni Tamari, MD10, Michal Sheleg, PhD11*, Daniel Rothenstein, PhD12*, Nitsan Halevy, MD13* and Jacob M. Rowe, MB, BS14

1Case Western Reserve University School of Medicine, Cleveland, OH
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
4The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
5Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Heights, OH
6Apheresis and Marrow Processing Laboratories, Baylor University Medical Cente, Dallas, TX
7Division of Hematology, Mayo Clinic, Rochester, MN
8Stem Cell Transplantation and Cellular Therapy Program, Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
9Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel
10Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Pluristem, Haifa, Israel
12Pluristem Ltd., Haifa, Israel
13Pluristem Ltd., Haifa, AL, Israel
14Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel

Vaibhav Agrawal, MD1, Hoda Pourhassan, MD1*, Ni-Chun Tsai, MS2*, Dat Ngo, PharmD3*, Paul B. Koller, MD1, Monzr M. Al Malki, MD1, Amandeep Salhotra, MD1, Haris Ali, MD1, Karamjeet S. Sandhu, MD1, Shukaib Arslan, MD1*, Brian J Ball, MD1, Salman Otoukesh, MD1*, Idoroenyi Amanam, MD1, Andrew S. Artz, MD, MS1, Pamela S. Becker, MD, PhD1, Forrest M. Stewart, MD1*, Eileen P. Smith, MD1, Peter T. Curtin, MD1, Anthony S. Stein, MD1, Guido Marcucci, MD1, Stephen J Forman, MD1, Ryotaro Nakamura, MD1*, Vinod A. Pullarkat, MD1* and Ibrahim Aldoss, MD1

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
3Department of Pharmacy, City of Hope National Medical Center, Duarte, CA

Maxime Jullien, MD1*, Amandine Le Bourgeois, MD1*, Pierre Peterlin, MD2*, Alice Garnier, MD1*, Thierry Guillaume, MD, PhD1*, Marie C Béné, PharmSciD, PhD3* and Patrice Chevallier, MD1

1Hematology Department, Nantes University Hospital, Nantes, France
2Nantes University Hospital, Nantes, France
3Biology Department, Nantes University Hospital, Nantes, France

Ashvind Anand Prabahran, MBBS1,2,3*, Rachel M Koldej, PhD4,5*, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA2,3,6 and David Ritchie, MB ChB, PhD1,2,3

1Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
2ACRF Translational Research Laboratory, The Royal Melbourne Hospital, Parkville, VIC, Australia
3Department of Medicine, The University of Melbourne, Parkville, VIC, Australia
4Department of Medicine (RMH), The University of Melbourne, Parkville, VIC, Australia
5ACRF Translational Research Laboratory, Royal Melbourne Hospital, Parkville, VIC, Australia
6Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Australia

Rama Al Hamed1,2*, Myriam Labopin, MD1*, Wolfgang Bethge, MD3*, Arnold Ganser, MD4*, Arne Brecht, MD5*, Johanna Tischer, MD6*, Nicolaus Kröger, MD7*, Donald Bunjes, MD8*, Hermann Einsele, MD9, Mareike Verbeek, MD10*, Igor Wolfgang Blau, MD11*, Martin Kaufmann, MD12, Eolia Brissot, MD, PhD1*, Ali Bazarbachi, MD, PhD13, Christoph Schmid, MD14*, Alexandros Spyridonidis15*, Arnon Nagler, MD16, Fabio Ciceri, MD17* and Mohamad Mohty, MD PhD1

1EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France
2Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, NY
3University Hospital Tuebingen, Medical Center II, Hematology & Oncology, Tuebingen, Germany
4Hannover Medical School, Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany
5Deutsche Klinik fuer Diagnostik KMT Zentrum, Wiesbaden, Germany
6Klinikum Grosshadern, Med. Klinik III, Munich, Germany
7Department for Stem Cell Transplantation, University Medical Center, Hamburg, Germany
8Klinik fuer Innere Medzin III, Universitätsklinikum Ulm, Ulm, Germany
9Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
10Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Clinic and Policlinic for Internal Medicine III, Munich, Germany
11Medizinische Klinik m. S. Hämatologie , Onkologie und Tumorimmunologie, Charité Universitätsmedizin, Berlin, Germany
12Abteilung für Hämatologie, Onkologie und Palliativmedizin, Robert-Bosch-Krankenhaus Stuttgart, Stuttgart, Germany
13American University of Beirut Dept. of Medicine, Beirut, Lebanon
14Augsburg University and Medical Faculty, Augsburg, Germany
15Hematology Stem Cell Transplant Unit, School of Medicine, University of Patras, PATRA, Greece
16Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
17Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

Chengjuan Luo1*, Shaoyan Hu, MD, PhD2, Xiaoqin Feng3*, Jun Lu, MD2*, Hua Zhu, PHD4*, Yongsheng Ruan, MD5*, Jing Ling, MD2*, Changying Luo6*, Jianmin Wang6*, Yuanyuan Tian2*, Bohan Li, MM2*, Wing H. Leung, MD, PhD7 and Jing Chen, DO8

1Shanghai Children's Medical Center, Shanghai, China
2Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
3Dept. of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
4Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
5Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
6Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
7Department of Pediatrics and Adolescent Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong
8Department of Hematology/Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Hangzhou, CO, China

Aron Flagg, MD1*, Rohaum Hamidi, MD2*, Yanhong Deng, PhD3*, Niketa C. Shah, MD4, Lakshmanan Krishnamurti, MD5 and Zili He, MS3*

1Department of Pediatrics, Section of Hematology/Oncology, Yale School of Medicine, New Haven, CT
2Department of Pediatrics, Yale School of Medicine, New Haven, CT
3Yale School of Public Health, New Haven, CT
4Department of Pediatrics, Section of Hematology/Oncology and Stem Cell Transplant, Yale School of Medicine, New Haven, CT
5Section of Pediatric Hematology/Oncology/BMT, Yale School of Medicine, New Haven, CT

Jim A. Connelly, MD1, Eden Biltibo, MD, MS1, Karina Wilkerson, MSN, NP2,3*, Adriana Seber, MD, MS4, Roseane V Gouveia5*, Carmem Bonfim, MD, PhD6*, Belinda Pinto Simões, MD, PhD7*, Erfan Nur, MD, PhD8, Biljana N. Horn, MD9, Michael Eckrich, MD, MPH10, Rabi Hanna, MD11, Nathalie Dhedin, MD12*, Fahed Almhareb, MBBS, FACP13, Mahmoud Aljurf, MD13, Hemalatha G. Rangarajan, MD14, Katie S. Gatwood, PharmD15*, Lindsay Orton, PharmD1*, Carrie Lynn Kitko, MD16, Mohsen Alzahrani17*, Ali Debsan Alahmari, MBBS, MD, MNAMS18*, Josu De La Fuente, MD, PhD19* and Adetola A. Kassim, MBBS, MS20,21

1Vanderbilt University Medical Center, Nashville, TN
2Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt-Meharry Sickle Cell Disease Center of Excellence, Vanderbilt University School of Medicine, Nashville, TN
4Hospital Samaritano, Sao Paulo, SP, Brazil
5Hospital Sao Camilo Pompeia, Pediatric Oncology and Hematopoietic Cell Transplantation, São Paulo, Brazil
6Bone Marrow Transplantation unit, Federal University of Parana, Curitiba, PR, Brazil
7Center for Cell-Based Therapy, Hemotherapy Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
8Department of Clinical Hematology, Slotervaart Hospital, Amsterdam, Netherlands
9Department of Pediatrics, University of Florida, Gainesville, FL
10Levine Children's Hospital At Carolinas Medical Center, Charlotte, NC
11Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Cleveland Clinic Foundation, Cleveland, OH
12St-Louis Hospital, APHP, Adolescents and Young Adults Hematology Department, Paris, France
13Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
14Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Childrens Hospital, Columbus, OH
15Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
16Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN
17Division of Adult Hematology and SCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia
18King Faisal Hospital & Research Ctr., Riyadh, SAU
19Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
20Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN
21Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Nashville, TN

Jieling Jiang, MD1*, Sanbin Wang2*, Xiaojin WU, MD3*, Xiao Lin Yin, MD4*, Xiaofan Li, MD, PhD5, Dong Wu6*, Quanyi Lu, PhD7*, Kourong Miao8*, Houcai Wang9* and Jiong Hu, MD1

1Shanghai institute of hematology, Ruijin hospital affiliated to Shanghai Jiao Tong university school of medicine, Shanghai, China
2920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, China
3Department of hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, CHN
4923th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Nanning, China
5Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
6Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
7Department of hematology, Zhongshan hospital affiliated to Xiamen university, Xiamen, China
8The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People’s Hospital in Nanjing, Key Laboratory of Hematology of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalize, Nanjing, China
9Department of hematology, Shanghai tenth people's hospital, Shanghai, China

Shulian Chen1*, Xiaoyu Zhang1*, Weihua Zhai1*, Yi He2*, Sizhou Feng2*, Mingzhe Han1*, Ting Niu3, Yajing Xu, MD&PhD4, Guangxun Gao, MD5*, Shengjin Fan6*, Zeping Zhou7*, Fang Zhou, PhD8*, Xi Rui9*, Li Liu, MD10*, Wei Yang, MD11*, Qifa Liu, MD12, Xi Zhang, M.D., Ph.D.13* and Erlie Jiang1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
3West China Hospital of Sichuan University, Chengdu, Sichuan, China
4XiangYa Hospital Central South University, Hunan, China
5Department of Hematology, Xijing Hospital, Xi'An, China
6The First Affiliated Hospital of Harbin Medical University, Harbin, CHN
7Second Affiliated Hospital of Kunming Medical University, KunMing, China
8Department of Hematology, The 960th Hospital of the People's Liberation Army, Jinan, China
9The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, lanzhou, China
10Tangdu Hospital Affiliated to the Fourth Military Medical University, Xi'an, China
11Shengjing Hospital of China Medical University, Shenyang, China
12Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
13Department of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China

Silvia Park1*, Daehun Kwag2*, Su Yeon Bang, MD3*, Jong-Hyuk Lee, M.D.4*, Gi June Min, M.D., Ph.D.5*, Sung-Soo Park, M.D., Ph.D.6*, Seung-Ah Yahng, M.D., Ph.D.7*, Young-Woo Jeon, M.D., Ph.D.8*, Seung-Hwan Shin, M.D., Ph.D.9*, Jae-Ho Yoon, M.D., Ph.D.10, Sung-Eun Lee, MD11*, Byung-Sik Cho, M.D., Ph.D.10*, Ki-Seong Eom, M.D., Ph.D.10*, Seok Lee, M.D., Ph.D.10, Yoo-Jin Kim, M.D., Ph.D.10, Chang-Ki Min, MD, PhD10*, Seok-Goo Cho, M.D., Ph.D.10*, Jong Wook Lee, M.D., Ph.D.10 and Hee-Je Kim, M.D., Ph.D.10

1Department of Hematology, Catholic Hematology Hospital,Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, Korea, Republic of (South)
2Department of Hematology, Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, AL, South Korea
4Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
5Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, KOR
7Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of (South)
8Department of Hematology, Yeouido St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
9Dep. of Hematology, Hematology Institute, Eunpyeung St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
10Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
11Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Houston, TX

Xingying Li1*, Jun Yang, MD1*, Liping Wan1*, Yu CAI1*, Kun Zhou1*, Chongmei Huang2*, Yin Tong1*, Huiying Qiu1* and Xianmin Song, phd3*

1Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, shanghai, China
3Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Aswin Anand PAI, MSc1*, Uday Kulkarni, MD, DM1*, Binu Susan Mathew, MBBS, MD2*, Nayanthara KB, MSc1*, John C Panetta, PhD3*, Sujith Karumathil, MBBS, MD, DM1*, Aby Abraham, MD, DM1*, Vikram Mathews, MD, DM1, Biju George, MD, DM1 and Poonkuzhali Balasubramanian, MSc, PhD1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Clinical Pharmacology, Christian Medical College, Vellore, India
3Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN

Omnia Elebyary1,2*, Noah Fine1*, Chunxiang Sun1*, Sourav T Saha1*, Erin Watson2*, Bryan Coburn3*, Jeffrey H. Lipton4 and Michael Glogauer1,2*

1Faculty of Dentistry, University of Toronto, Toronto, ON, Canada
2Dental Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada
3Department of Medicine, Division of Infectious Diseases, University Health Network, Toronto, ON, Canada
4Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Elisabeth Dovern, MD1*, Mesire Aydin1*, Man Wai Tang, PhD1, Liesbeth E.M. Suijk1*, Gerianne M. Hoogendoorn1*, Charlotte F.J. Van Tuijn, MPH1*, Jean-Louis Kerkhoffs2, Caroline E. Rutten, MD, PhD1*, Sacha S. Zeerleder, MD, PhD3*, Mette D. Hazenberg, MD, PhD1*, Bart J Biemond1 and Erfan Nur, MD, PhD1

1Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
2Department of Hematology, HagaZiekenhuis, The Hague, Netherlands
3Department of Hematology, Luzerner Kantonsspital, Luzern, Switzerland

Rosa Toenges, MD1*, Fabian Lang, MD1*, Rakhshinda Ghaffar1*, Vera Schlipfenbacher, MD1*, Julia Riemann, MD1*, Salem Ajib, MD1*, Khouloud Kouidri, MD1*, Anjali Cremer, MD1*, Weber Bodo, MD1*, Thu Nguyen, MD1*, Antje Knoch1*, Janne Vehreschild, MD1,2,3*, Hubert Serve, MD1,4,5 and Gesine Bug, MD1*

1Dept. of Medicine, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany
2Department I for Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
3German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany
4Frankfurt Cancer Institute, Goethe-University, Frankfurt, Germany
5German Cancer Consortium (DKTK) and German Cancer Research Centre (DKFZ), Frankfurt, Germany

Buyeon Heo, MS1*, Myung-Won Lee, M.D., Ph.D.2*, Su-Young Choi, B.A.3*, Pham Thi Thuy Duong, M.D.3*, Yunseon Jang, Ph.D.4*, Jung-Hyun Park, Ph.D.4*, Deog-Yeon Jo, M.D., Ph.D.5, Jaeyul Kwon, Ph.D.6* and Ik Chan Song, M.D., Ph.D.7

1Department of Medical Science, College of Medicine, Chungnam National Univeristy, Daejeon, Korea, Republic of (South)
2Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea, Republic of (South)
3Department of Medical Science, Chungnam National University, Daejeon, Korea, Republic of (South)
4Translational Immunology Institute, Chungnam National University, Daejeon, Korea, Republic of (South)
5Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)
6Department of Medical Science, Chungnam National Univeristy, Daejeon, Korea, Republic of (South)
7Department of Internal Medicine, Chungnam National University, Daejeon, Korea, Republic of (South)

Muhammad Umair Mushtaq, MD1, Joe S Al-Ramahi, MD1*, Kevin S Li1*, Moazzam Shahzad, MD1*, Sibgha Gull Chaudhary, MD1*, Ramesh Balusu, PhD1, Nausheen Ahmed, MD2*, Rajat Bansal, MD1*, Haitham Abdelhakim, MD3, Leyla O. Shune, MD1, Anurag K. Singh, MD1, Sunil H Abhyankar, MD4 and Joseph P. McGuirk, DO1

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
4University of Kansas Cancer Center, Westwood, KS

Antonio Perez, MD, PhD1,2*, María Ovidia López3*, Rocío González-Sacristán4*, Mercedes Gasior5*, Antonio Marcos6*, Raquel De Paz Arias, PhD7*, José María Alonso8*, Carmen Mestre-Durán9*, Karima Al-Akioui9*, Cristina Ferreras, PhD10*, Antonio Balas, PhD11*, Jose Luis Vicario, PhD11*, Carlos Solano, MD, PhD12,13,14, Belén Estébanez15*, Esther Ramos-Boluda4*, Carlos Jiménez3* and Francisco Hernández-Oliveros, MD, PhD16*

1Hospital La Paz Institute for Health Research, Madrid, Spain
2Hemato-Oncology Pediatric Service, Hospital Universitario La Paz, Madrid, Spain
3Nephrology, University Hospital La Paz, Madrid, Spain
4Intestinal Rehabilitation and Transplant, University Hospital La Paz, Madrid, Spain
5Hematology Department, University Hospital La Paz, Madrid, Spain., Madrid, Spain
6Hematology, University Hospital La Paz, Madrid, Spain
7Hematology, Hospital Universitario La Paz-Idipaz, Madrid, ESP
8Urology, University Hospital La Paz, Madrid, Spain
9Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain, Madrid, Spain
10Translational Research In Pediatric Oncology, Hematopoietic Transplantation and, Madrid, ESP
11Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain, Madrid, Spain
12Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
13Department of Medicine, University of Valencia, Valencia, Spain
14Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
15University Hospital La Paz, Madrid, Spain
16Pediatric Surgery, University Hospital La Paz, Madrid, Spain

Alicja Sadowska-Klasa1*, Anna Dukat-Mazurek2*, Hanna Zielińska2*, Joanna Dębska-Zielkowska2*, Grażyna Moszkowska2*, Agnieszka Piekarska, MD, PhD1*, Andrea Gallamini, MD3,4 and Jan Maciej Zaucha, MD1*

1Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
2Department of Medical Immunology, Medical University of Gdansk, Gdansk, Poland
3Research and Clinical Innovation Department, Antoine Lacassagne Cancer Center, Nice, France
4International Advisory Council, Medical University of Gdansk, Gdansk, Poland

Filip Ionescu, MD1, Eloho Ajayi, MD2*, Aamia Leach, ARNP3*, Melissa Alsina, MD**4, Nelli Bejanyan, MD5, Omar Castaneda-Puglianini, MD4*, Hany Elmariah, MD, MS5, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP6, Doris K. Hansen, MD4, Michael D. Jain, MD, PhD4, Farhad Khimani, MD5, Aleksandr Lazaryan, MD, PhD, MPH7, Hien D. Liu, MD4, Frederick L. Locke, MD8, Bryan McIver9*, Asmita Mishra, MD4, Michael Nieder, MD4*, Jose Ochoa, MD4, Lia Perez, MD4*, Joseph Pidala, MD, PhD4, Aliyah Baluch, MD10*, Olga Klinkova11*, Rod Quilitz11*, Taiga Nishihori, MD4 and Rawan Faramand, MD12

1Department of Hematology and Oncology, H. Lee Moffitt Cancer Center/University of South Florida, Tampa, FL
2Infectious Diseases, Moffitt Cancer Center, Tampa, FL
3Bone Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
5Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
6Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Centre, Tampa, FL
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Endocrine Oncology, H. Lee Moffitt Cancer Center, Tampa, FL
10Department of Bone Marrow Transplant Infectious Diseases, H. Lee Moffitt Cancer Center, tampa, FL
11Department of Bone Marrow Transplant Infectious Diseases, H. Lee Moffitt Cancer Center, Tampa, FL
12Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Ayman Sayyed, BMBS, MRCP1*, Leeann Wilson1*, Vered Stavi1*, Shiyi Chen2*, Jonas Mattsson1*, Jeffrey H. Lipton1, Dennis D. H. Kim3, Auro Viswabandya1, Rajat Kumar1, Wilson Lam1, Arjun D. Law, MD1*, Armin Gerbitz1*, Ivan Pasic1*, Igor Novitzky-Basso1* and Fotios V. Michelis1*

1Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network / Princess Margaret Cancer Centre, Toronto, ON, Canada

*signifies non-member of ASH